A Study of Safety and Efficacy of Infliximab (Remicade) in Patients With COPD
Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and effectiveness of infliximab
(Remicade) in patients with Chronic Obstructive Pulmonary Disease (COPD). Infliximab
(Remicade) targets specific proteins in the body's immune system to help control the
development of inflammation to help reduce painful disease.